Pemphigus foliaceus successfully treated with mycophenolate mofetil as a steroid-sparing agent

Kenneth H. Katz, James G. Marks, Klaus F. Helm

Research output: Contribution to journalArticle

37 Scopus citations

Abstract

Pemphigus foliaceus is an autoimmune blistering disease of unknown origin with antibodies produced against desmoglein 1, an adhesive protein found in the desmosomal cell junction in the suprabasal layers of the epidermis. The disease is primarily treated with corticosteroids and corticosteroid-sparing immunosuppressive agents. We report a case of pemphigus foliaceus successfully treated with mycophenolate mofetil. It remains to be seen whether this agent has a significant effect on the course of the disease and remission induction.

Original languageEnglish (US)
Pages (from-to)514-515
Number of pages2
JournalJournal of the American Academy of Dermatology
Volume42
Issue number3
DOIs
Publication statusPublished - Mar 2000

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this